FSMDX
Price
$36.05
Change
-$0.08 (-0.22%)
Updated
Nov 13 closing price
SWMCX
Price
$71.10
Change
-$0.16 (-0.22%)
Updated
Nov 13 closing price
Ad is loading...

FSMDX vs SWMCX

Header iconFSMDX vs SWMCX Comparison
Open Charts FSMDX vs SWMCXBanner chart's image
Fidelity Mid Cap Index
Price$36.05
Change-$0.08 (-0.22%)
VolumeN/A
CapitalizationN/A
Schwab ® US Mid-Cap Index
Price$71.10
Change-$0.16 (-0.22%)
VolumeN/A
CapitalizationN/A
FSMDX vs SWMCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSMDX vs. SWMCX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMDX is a Buy and SWMCX is a Buy.

FUNDAMENTALS
Fundamentals
FSMDX has more cash in the bank: 36.3B vs. SWMCX (1.73B). SWMCX pays higher dividends than FSMDX: SWMCX (1.37) vs FSMDX (1.28). FSMDX was incepted earlier than SWMCX: FSMDX (13 years) vs SWMCX (7 years). FSMDX is a more actively managed with annual turnover of: 9.00 vs. SWMCX (8.00). FSMDX (0) and SWMCX (0) have matching initial minimum investment requirements. SWMCX (33.38) and FSMDX (33.08) have marching annual gain over last year. SWMCX (63.61) and FSMDX (62.77) have equivalent 5 years return.
FSMDXSWMCXFSMDX / SWMCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years7 years-
Gain YTD20.41320.65799%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets36.3B1.73B2,099%
Annual Yield % from dividends1.281.3794%
Returns for 1 year33.0833.3899%
Returns for 3 years11.5711.04105%
Returns for 5 years62.7763.6199%
Returns for 10 years126.10N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SOPA0.93N/A
+0.01%
Society Pass Incorporated
BCH22.96-0.16
-0.69%
Banco de ChileAmerican
EP6.27-0.12
-1.88%
Empire Petroleum Corp
PRCT92.25-3.30
-3.45%
PROCEPT BioRobotics Corp
ATXS10.63-0.53
-4.75%
Astria Therapeutics